A Drug–Drug Interaction Study of Zanubrutinib with Moderate and Strong CYP3A Inhibitors in Patients with B-Cell Malignancies

Opat, Stephen (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Details

Project Description

NMA HREC Reference Number: CALHN HREC red R20200607
NMA SSA Reference Number: SSA/70111/MonH-2020-242090(v2)
Monash Health Reference: RES-20-0000-858X

Status	Active
Effective start/end date	25/11/20 → 24/11/25

View all

View less

Keywords

clinical trial
treatment efficacy
treatment safety
lymphoma